z-logo
open-access-imgOpen Access
COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
Author(s) -
Seyedi Seyed Javad,
Sadeghi Hossein,
Kianifar HamidReza,
Hamedi Abdolkarim,
Saeidinia Amin
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5782
Subject(s) - medicine , hypertonic saline , cystic fibrosis , covid-19 , regimen , saline , pulmonary infection , pneumonia , intensive care medicine , gastroenterology , immunology , pediatrics , disease , infectious disease (medical specialty)
Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a treatment regimen against COVID‐19 infection after further investigations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here